Yu-wei C. Fang
TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 84 publications
GLP-1 receptor agonists reduce dementia and Alzheimer disease risk in diabetic Patients with CKD.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: February 16, 2026
Dermatologic outcomes associated with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a large-scale target trial emulation.
Journal: Frontiers in endocrinology
Published: February 01, 2026
Cardiorenal Outcomes of Sodium-Glucose Cotransporter 2 Inhibitors in Type 2 Diabetes Mellitus With Nephrotic-Range Proteinuria: A Multi-Institutional Target Trial Emulation.
Journal: Diabetes, obesity & metabolism
Published: January 31, 2026
Target trial emulation of sodium glucose cotransporter 2 inhibitors and clinical outcomes in diabetes and end stage kidney disease.
Journal: Scientific reports
Published: January 02, 2026
Clinical effects of glucagon-like peptide-1 receptor agonist in type 2 diabetes with low body mass index: findings from large-scale emulated target trials.
Journal: International journal of medical sciences
Published: December 20, 2025
Glucagon-like peptide-1 receptor agonists and cardiovascular outcomes in dialysis patients with type 2 diabetes: a real-world propensity score-matched study.
Journal: Clinical kidney journal
Published: December 20, 2025
Cardiorenal Outcomes of Dapagliflozin vs. Empagliflozin in Advanced Chronic Kidney Disease and Diabetes.
Journal: Clinical pharmacology and therapeutics
Published: December 17, 2025
Real-world evidence of finerenone in Type 2 diabetes: addressing confounding and follow-up duration.
Real-world evidence of finerenone in Type 2 diabetes: addressing confounding and follow-up duration.
Journal: European heart journal. Cardiovascular pharmacotherapy
Published: December 05, 2025
Colchicine use after acute myocardial infarction is associated with reduced dialysis dependence in advanced chronic kidney disease.
Journal: Scientific reports
Published: November 09, 2025
Associations Between PFAS Exposure and HPG Axis Hormones in U.S. Women.
Journal: Life (Basel, Switzerland)
Published: October 29, 2025
Association of glucagon-like peptide-1 receptor agonist use with clinical outcomes in patients with rheumatoid arthritis and type 2 diabetes.
Journal: Journal of diabetes investigation
Published: October 24, 2025
Last Updated: 09/26/2026